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High phenotypic variation in diet-induced obesity in male C57BL/6J inbred mice suggests a molecular model to
investigate non-genetic mechanisms of obesity. Feeding mice a high-fat diet beginning at 8 wk of age resulted in a 4-
fold difference in adiposity. The phenotypes of mice characteristic of high or low gainers were evident by 6 wk of age,
when mice were still on a low-fat diet; they were amplified after being switched to the high-fat diet and persisted even
after the obesogenic protocol was interrupted with a calorically restricted, low-fat chow diet. Accordingly,
susceptibility to diet-induced obesity in genetically identical mice is a stable phenotype that can be detected in
mice shortly after weaning. Chronologically, differences in adiposity preceded those of feeding efficiency and food
intake, suggesting that observed difference in leptin secretion is a factor in determining phenotypes related to food
intake. Gene expression analyses of adipose tissue and hypothalamus from mice with low and high weight gain, by
microarray and qRT-PCR, showed major changes in the expression of genes of Wnt signaling and tissue re-modeling in
adipose tissue. In particular, elevated expression of SFRP5, an inhibitor of Wnt signaling, the imprinted gene MEST and
BMP3 may be causally linked to fat mass expansion, since differences in gene expression observed in biopsies of
epididymal fat at 7 wk of age (before the high-fat diet) correlated with adiposity after 8 wk on a high-fat diet. We
propose that C57BL/6J mice have the phenotypic characteristics suitable for a model to investigate epigenetic
mechanisms within adipose tissue that underlie diet-induced obesity.
Citation: Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, et al. (2006) Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS
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Introduction
Obesity is a multifactorial disease in which inherited allelic
variation, together with environmental variation, determines
the predisposition of an individual to developing the disease.
Although the evidence in support of a genetic component to
the development of obesity is overwhelming [1–3], and a
number of promising candidate genes are being tested as
underlying causes of obesity [4], it remains difﬁcult to
quantify the genetic contribution to the obesity epidemic
during the past 25 y, a period too short for the accumulation
of additional obesogenic alleles. Twin studies indicate that
the contribution of heritability to the obese phenotype may
be as high as 70% [1,5]; however, this estimate includes allelic
variation as well as genetic inﬂuences that are dependent
upon a particular environment. Genomic and environmental
variables are probably not independent, but gene-environ-
mental interactions unique to each individual will determine
the obese phenotype. Indeed it has been proposed that
interactions between obesity genotypes and an obesogenic
environment will synergistically increase the frequency of
obesity [6]. Therefore, determining how allelic and environ-
ment variations interact to determine obesity phenotypes are
critical for an understanding of the obesity epidemic.
Although we understand little regarding the interactions
between genes and the environment that are associated with
the development of obesity, the ﬁndings that some inbred
strains of mice are susceptible to obesity when fed a high-fat
diet, whereas others are resistant, clearly indicate that certain
combinations of alleles are more obesogenic than others [7,8].
In addition, over- or under-expression of selective genes can
have major effects on diet-induced obesity, but little or no
effect when animals are fed a low-fat diet [9–11]. To develop a
model system to discover the basis for environmental
components of obesity, we have taken advantage of diet-
induced obesity in highly inbred C57BL/6J (B6) mice. Male
mice of this inbred strain are more susceptible to obesity
when fed a high-fat diet [12] than other strains such as 129
mice [13]. However, we and others have observed large
variations in adiposity and diabetes among the individual B6
mice, even when maintained under seemingly identical
environmental conditions [14–16]. We hypothesized that in
the absence of allelic variation among the animals, pheno-
typic variation would be determined by either unstable
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of genes of energy balance. We have developed an exper-
imental strategy to determine variations in obesity pheno-
types in a large population of B6 mice and to analyze patterns
of gene expression by microarray analysis and quantitative
RT-PCR (qRT-PCR) to identify metabolic pathways associated
with extreme adiposity phenotypes.
In this paper, we present evidence for highly variable, but
stable, obesity phenotypes among B6 mice by 6 wk of age,
even before they are fed a high-fat diet, indicating that some
mice are destined to be high gainers, while others from the
same litter are to become low gainers. An analysis of the
energy cost of weight gain suggests that variation in both
metabolic efﬁciency and food intake are determinants of the
obesity phenotype. The microarray analysis of gene expres-
sion in adipose tissue from high and low gainers suggests that
the Wnt signaling pathway and genes associated with
vascularization and tissue remodeling are major regulatory
points controlling differences in adipose tissue expansion
and that some of these genes are differentially expressed even
before mice are fed a high-fat diet.
Results
Non-Genetic Variation in Body Weight and Composition
Genetically identical 8-wk-old male B6 mice developed a
highly variable obesity after being fed a diet containing 58
Kcal % saturated fat (Figure 1). Body weights of 219 mice fed
a high-fat diet for 4 wk were distributed in a bell-shaped
curve ranging from 24–37 g (Figure 1A). Based upon
determinations of body composition using nuclear magnetic
resonance (NMR), body weight variation was primarily caused
by changes in adiposity (Figure 1B) with a much smaller,
though signiﬁcant contribution, from lean body mass (Figure
1C). This morphometric evidence shows that variability in fat
mass among individual B6 mice at the extreme ends of the
distribution leads to about a 4-fold difference in fat mass
after only 4 wk on a high-fat diet. Critical to the experimental
design to identify factors determining diet-induced obesity
was the necessity to minimize variation not related to the
effects of a high-fat diet, such as that coming from variation
in litter size with its subsequent effects on the size of pups at
weaning, since it has been shown that litter size can have
strong effects on development of adiposity [17–19]. Regres-
sion analysis of body weight at weaning versus changes in
adiposity (fat mass/lean mass, DFM/LM) and analysis of
variance (ANOVA) of litter size versus changes in adiposity
(DFM/LM) at 12 wk (Figure 1D and 1E) barely reached
signiﬁcance and the R
2 indicated that the variation in wean
weight contributed about 3 % to the variance in adiposity.
Breeding and dietary conditions in our facility produced
progeny with low variability in body weight (at 3 wk of age,
the 112 mice in Figure 1B had a mean and standard deviation
for body weight of 10.99 6 1.23 g). Thus the variation in body
weight in 12-wk-old mice, following 4 wk on a high-fat diet,
was not signiﬁcantly inﬂuenced by differences in litter size
and body weights of pups prior to weaning.
The Stability of the Adiposity Phenotype
The observed variation could be the result of stochastic,
random variation in the activity of any of a large number of
metabolic pathways associated with the development of
obesity. Alternatively, the obesity phenotype in individual
mice could be ﬁxed, and once acquired, stable, a necessary
condition for a speciﬁc epigenetic mechanism. To determine
the stability of the obesity phenotype 107 male B6 mice were
fed a low-fat chow diet ad libitum from weaning until they
were 8 wk of age and then a high-fat diet ad libitum for 6 wk,
until they were 14 wk of age to induce obesity (Figure 2). At the
end of the 14
th wk, we returned the mice to the low-fat chow
diet (restricted to 80% of the amount consumed by each
mouse from wk 7–8) until they reach a new low plateau. We
expected that body weights would return to that of mice not
fed a high-fat diet, which would lie between 22–26 g. Although
the body weights of all mice declined during this 2-wk period
of restricted low-fat feeding, it is striking that all mice did not
arrive at the same plateau; rather, their weights were higher,
between 23–35 g and distributed over a range proportional to
that observed before caloric restriction. The metabolism and
behavior of the high gainer mice had adapted to maintain a
higher body weight and adiposity even when they were fed a
low-fat restricted diet, reminiscent of the behavior of obese
humans who defend their body weights when fed a restricted
diet [20,21]. At the beginning of the 17
th wk the mice were
again fed the high-fat diet and they immediately responded by
increasing their adiposity at a rate commensurate with that
observed during the ﬁrst exposure to the high-fat diet. The
rate of gain of the top 10 % was 2.2 times greater than that of
the lower 10 % from the 8
th to the 14
th wk (2.54 6 0.04 versus
1.15 6 0.09 g/wk) and also 2.2 times greater from the 16
th to
the 22
nd wk (3.29 6 0.05 versus 1.51 6 0.11g/wk). We conclude
that the obese phenotypes of B6 mice fed a high-fat diet are
stable and consistent with a mechanism that causes a
permanent change in energy metabolism.
We have shown in the previous section that litter size and
body weights at weaning (3 wk of age) did not correlate with
body weights at 12 wk of age, after 4 wk on a high-fat diet
(Figure 1D). However, the correlation of body weights of mice
at 8 wk of age fed a low-fat diet to the change in fat mass from
8–12 wk of age was highly signiﬁcant (R ¼ 0.364; P ¼ 7.99 3
10
 05). This evidence together with inspection of the growth
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Synopsis
Genetic models to explain the obesity epidemic are inadequate
because the emergence of this epidemic over the past 30 y has been
too rapid to allow for the appearance of new mutant genes. The
authors show that diet-induced obesity among genetically identical
mice is characterized by highly variable and stable phenotypes that
are established in mice early in life, even before they become
exposed to an obesogenic environment. Furthermore, strong
associations occur between susceptibility to obesity and the
expression of genes implicated in processes that regulate cellular
development. Previous studies have shown that abnormal regu-
lation of such genes by epigenetic mechanisms is linked with the
development of cancer. Epigenetic mechanisms involve chemical
processes that change chromatin structure and gene expression
without changing the genetic code. Accordingly, epigenetic
modifications of gene structure through nutritional and physiolog-
ical stress provide mechanisms for inducing obesity that are
independent of new mutations to the genome. Experimental
models based upon genetically identical mice provide powerful
tools for identifying epigenetic and environmental mechanisms
causing obesity and other chronic diseases.curves in Figure 2 show that differences between high and low
gainers have been established even before the mice have
received a high-fat diet. The high-fat diet accentuates differ-
ences in energy balance that already appear to exist among
progeny. The potentiality to express these phenotypic differ-
ences must have been established earlier in development, but
were not evident from body weight phenotypes at weaning.
The Cost of Weight Gain or Metabolic Efficiency
The energy cost of weight gain is a complex process that
depends on many factors. The major variable in our dietary
studies has been the fat content of diets 5053 and D12331,
containing 12 and 58 kcal % fat respectively, while protein
content at 23.6 and 16.5 kcal %, respectively, is within a
normal range that does not stimulate thermogenesis [22]. The
early emergence and stability of phenotypic differences
observed in Figure 2, even during caloric restriction, suggests
that diet per se is not the underlying mechanism for the
variability in obesity. To address this issue further it was
necessary to modify our standard protocol to achieve
minimal food spillage, which can be considerable with B6
mice fed ad libitum. The feeding protocol was based upon
ﬁrst restricting the available food to one pellet, but still in
excess and available ad libitum, that was given to the mice in
the late afternoon of each day beginning at wk 7 when the
mice were on a low-fat diet. At the beginning of the 8
th wk
when the high-fat diet was started, the amount of diet, still in
one pellet, given to the mice was titrated to a level where
approximately 80% of the mice left a portion of the food
pellet in the hopper. By the end of the ﬁrst week this amount
was estimated at 2.7 g and held constant at that amount for
the remainder of the experiment. The amount of food
consumed for each mouse was estimated daily and food
consumption is presented as the amount consumed per
mouse per week for the top 20 high gainers and bottom 20
low gainers (Figure 3). Body weights for the high gainers were
signiﬁcantly different from low gainers after 1 wk on a high-
fat diet and they become steadily greater during the
following weeks. In contrast, food intake and the feeding
Figure 1. Establishing Variations in Adiposity in Diet-Induced Obesity in Male C57BL/6J Mice
Frequency distribution of body weight in 219 mice at 12 wk of age, after being fed a high-fat diet for 4 wk. (A) Regression analysis between the change
in body weight and fat mass (B) and change in body weight and lean body mass (C) from 8 and 12 wk of age as determined by NMR in 112 mice. (D)
Regression analysis between mouse weight at weaning and the percent change of the ratio of fat mass (FM) to lean mass (LM) per week, p¼.0105, n¼
220. Changes in the FM/LM ratio per wk were calculated from 8–12 wk of age or from 8–14 wk of age. (E) Average percent change of the ratio of FM/LM
per week for the various litter sizes, p ¼ .0406, n ¼ 220 (ANOVA).
DOI: 10.1371/journal.pgen.0020081.g001
Figure 2. Stability of the Adiposity Phenotype in B6 Mice
Male mice (n ¼ 107) were fed a low-fat chow diet (Picolab 5053) from
weaning to 8 wk of age, a high-fat diet (Research Diets D12331) from 8–
14 wk, then the low-fat chow diet, restricted to 80% of the amount
consumed from wk 7–8, during wk 15 and16, and finally, the high-fat diet
for wk 17–22. Mice were weighed weekly except during the food
restriction period when body weights were measured daily until they
had stabilized under these conditions. Food intake was measured weekly
starting from wk 7. At the end of wk 8, 14, 16, and 22, the body
composition of each mouse was analyzed by NMR. The body weight
curves of mice at the upper and lower 10% of the frequency distribution
at 22 wk of age are plotted in red and blue.
DOI: 10.1371/journal.pgen.0020081.g002
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each week by the food consumed for that week, was not
signiﬁcantly different between the high and low gainers until
the 4
th wk of high-fat feeding. Thus, although differences in
food intake appear to contribute to the long term variation
in obesity among mice, they did not appear to be a
determinant in establishing the initial differences in adipos-
ity. Important to physiological mechanisms related to
adiposity and food intake is the potential involvement of
leptin. Plasma leptin levels (mean 6 SD ¼ 78.9 6 29.9 ng/ml;
range 27.6–168; n ¼107) from mice in Figure 2 were strongly
correlated with adiposity after 6 wk on a high-fat diet (R ¼
0.617; p ¼ 1.42 3 10
 12).
Molecular Correlates Associated with Variation in
Adiposity
We have used microarray analysis of gene expression to
obtain a global view of the pathways of adipogenesis by which
genetically identical mice of the same age and sex and fed the
same diet differentially expand their fat mass. Using the
Applied Biosystems (Foster City, California, United States)
Expression Array System, as described in the Materials and
Methods, replicate analysis of a pool of RNAs from high and
low gainers was performed with RNA from both the
hypothalamus and inguinal fat depots. Analysis of expression
in inguinal fat revealed 792 genes that were over-expressed in
high gainers and 1,110 that were over-expressed in low
gainers at a signiﬁcance level of p , 0.01 and with a cutoff of
1.5 for over-expression in high and low gainers, respectively.
The difference in expression for high gainers/low gainers for
the complete data set ranged from þ23.9 (mesoderm speciﬁc
transcript, MEST) to  14.3 (lymphocyte antigen 74). In
contrast to the large number of genes with signiﬁcant
differences in expression in inguinal fat, only eight genes
showed altered expression in the microarray analysis of the
hypothalamus. However, none of the differences in micro-
array expression of these genes could be validated by qRT-
PCR with analysis of 20 individual high gainers and 20 low
gainers. In addition, another ten genes, which have been
localized to deﬁned regions in the hypothalamus and known
to be involved in food intake, showed no signiﬁcant differ-
ences in expression when analyzed by qRT-PCR. (See Table
S1 for data on gene expression in the hypothalamus.) Thus,
we conclude that variations in mRNA levels for components
of signaling pathways for food intake in the hypothalamus are
not signiﬁcantly variable between high and low gainers.
To interpret the large number of gene targets showing
signiﬁcant differences in gene expression in adipose tissue
the following strategy was developed:
The list of genes was inspected manually to identify those
with known functions in adipocyte biology. These could be
associated with the mature adipocyte, preadipocytes, or
vascular tissue.
Literature searches were performed on genes with highly
signiﬁcant differences to establish associations with adipose
tissue biology.
Individual adipose tissue samples from 20 high gainers and
20 low gainers were analyzed together with RNA samples
isolated from the stromal vascular and mature adipocyte
fractions on a custom-designed quantitative TaqMant Low
Density Array carrying 48 genes on the primary list (Table 1).
The analysis of the different fat pads was useful to ﬁlter out
genes expressed in contaminating cells, for example, lym-
phatic tissue in inguinal fat and the epididymus in epididymal
fat. A gene that was only expressed in one depot and in only a
few of the samples in an inconsistent pattern was eliminated
from further consideration.
Genes with highly signiﬁcant differences, but with no
published evidence for involvement in adipose biology, were
not pursued further at this time.
Transcription Factors
Transcription factors associated with adiposity generally
showed no changes in expression that reach signiﬁcance
between high gainers and low gainers. Exceptions included
Stat 4, Lef1 (a target of Wnt signaling), E2F2, (microarray
data), and the three factors GATA3, Lipin3, and Myc. The
expression of Lef1 in the stromal vascular fraction, its
absence from retroperitoneal fat and epididymal fat and
from the inguinal fat depots of many animals suggested that
Lef1 is expressed in lymphocytes that were trapped within the
inguinal fat depot. Similarly, GATA3 and Myc have been
implicated in the regulation of proliferation of preadipocytes
[23,24] and were considered viable candidates, but they did
not survive following analysis of other fat depots. Conse-
quently, none of the genes on the ﬁnal list of candidates were
transcription factors.
Biomarkers of the Adipocyte and Energy Metabolism
Similar to transcription factors strongly implicated in
adipogenesis, the biomarkers of the adipocyte and genes
encoding enzymes of energy metabolism showed remarkably
Figure 3. Chronology of Body Weight, Food Intake, and Metabolic Efficiency of Mice with Food Intake Restricted to an Amount Equivalent to That
Consumed by 80% of Experimental Mice
Twenty mice were in each group. Differences in phenotype between groups are marked by an asterisk (*) at a significance level of p , 0.01
DOI: 10.1371/journal.pgen.0020081.g003
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change was in the 1.78-fold increase in leptin (unpublished
data), a response expected from increased adiposity. Con-
sistent with this increase in mRNA levels, leptin levels in the
serum of mice in the experiment described in Figure 2
correlated signiﬁcantly with body weight (R¼0.617; p¼1.423
10
 12 ; n ¼ 107). The b3 adrenergic receptor was expected to
have reduced levels of expression in high gainers, but the
reduction was not signiﬁcant, possibly because 4 wk of a high-
fat diet did not achieve sufﬁciently high levels of adiposity to
down regulate its expression [25]. Signiﬁcantly reduced b3-
adrenergic receptor mRNA was observed in high gainers in a
preliminary analysis of adipose tissue after 12 wk on a high-
fat diet (unpublished data).
Table 1. Validation of Microarray Gene Expression Data
Symbol Name HG/LG Ratio Association with Adiposity (R) Reference(s) to
Adipose Tissue
Microarray qRT-PCR ING RP EPI
Ace Angiotensin converting enzyme 1.77 1.46  0.35  0.48  0.29 [58]
Adamts5 A disintegrin-like metalloprotease 1.90 2.07 0.08 [59]
Adpn Adiponectin 1.49 1.13  0.27 [60]
Agt Angiotensinogen 1.55 1.29  0.05  0.68  0.61 [58]
Aqp5 Aquaporin 5  2.94  16.70  0.50 [61]
Bmp3 Bone morphogenetic protein 3 1.81 1.81 0.56 [29]
Bmpr1a Bone morphogenetic protein receptor, type 1A 1.83 1.24  0.20 [62]
Cdh1 Cadherin 1  4.20  3.14 [63]
Celsr1 Cadherin EGF LAG seven-pass G-type receptor 1  2.65  1.67 [63]
Centa2 Centaurin, alpha 2 1.86 1.74 0.22 [64]
D3Bwg0562e DNA segment, Chr 3, 3.18 2.17 0.46
Dact2 Dapper homolog 2 2.98 1.83  0.12 [65]
Dkk2 Dickkopf homolog 2 2.83 1.64 0.02  0.26  0.18 [66]
Fgf1 Fibroblast growth factor 1 2.02 1.89  0.06 [67]
Folh1 Folate hydrolase 4.34 2.90 0.46 0.58 0.17
Fzd2 Frizzled homolog 2 1.61 1.82 . [27]
Fzd4 Frizzled homolog 4 1.43 1.44  0.19 [27]
Fzd6 Frizzled homolog 6 1.74  1.05 0.02 [27]
G6pc Glucose-6-phosphatase, catalytic 3.19 3.66
Gata3 GATA binding protein 3  3.06  4.00 0.05 [23]
Gemin6 Gem (nuclear organelle) assoc. protein 6 5.43  1.15  0.15
Igf2 Insulin-like growth factor 2 1.85 2.05  0.01 [68]
Klk6 Kallikrein 6  10.00  33.33 [53]
Lcn2 Lipocalin 2  2.45  1.87  0.17 [69]
Lef1 Lymphoid enhancer binding factor 1  4.74 n.d.  0.12 . [70]
Lipf Lipase, gastric 3.91 3.56 .
Lpin3 Lipin 3 1.93 1.64  0.14 [71]
Lrp11 Low density lipoprotein receptor-related protein 11 2.00 1.16  0.11 [72]
Lrp5 Low density lipoprotein receptor-related protein 5 1.55 1.17  0.14 [72]
Mat1a Methionine adenosyltransferase I, alpha 1.99 1.34
Mest Mesoderm specific transcript 23.90 25.20 0.66 0.69 0.60 [73]
Myc Myelocytomatosis oncogene  1.77  1.61  0.27 [24]
Nkd1 Naked cuticle 1 homolog 2.68 2.37 0.63 0.79 0.63 [74]
Npr3 Natriuretic peptide receptor 3 1.87 1.95 0.34 [75]
Omd Osteomodulin 2.40 1.58  0.36
Pdgfa Platelet derived growth factor, alpha 1.53 1.25  0.02 [76]
Peg3 Paternally expressed 3 3.34 3.46 0.25
Pik3cd Phosphatidylinositol 3-kinase cat. delta polypeptide  2.29  2.22  0.10 [77]
Plat Plasminogen activator, tissue 1.62 1.65  0.25 [78]
Ptn Pleiotrophin  4.39  4.54
Serpine6b Serine (or cysteine) proteinase inhibitor, member 6b  2.52 n.d. [51]
Serpine1 Serine (or cysteine) proteinase inhibitor, member 1 3.58 3.40 0.49 0.41 0.32 [51]
Sfrp4 Secreted frizzled-related sequence protein 4 1.67 1.78 0.14 [27]
Sfrp5 Secreted frizzled-related sequence protein 5 3.96 5.99 0.65 0.76 0.76 [27]
Thbs2 Thrombospondin 2 1.67 1.46 0.06 [59]
Tlr1 Toll-like receptor 1  2.32  1.97  0.15 0.36 0.09 [79]
Tna Clec3b, C-type lectin domain family 3, member b 3.96 1.18  0.15  0.26  0.22
Tnf Tumor necrosis factor  2.46  2.05 0.27 [59]
Tnfrsf12a Tumor necrosis factor receptor, member 12a 1.69 1.70 0.18 [59]
Tph2 Tryptophan hydroxylase 2 4.38 n.d.
Traf1 TNF receptor-associated factor 1  2.70  2.94 0.16 [59]
Vegfa Vascular endothelial growth factor A 1.67 1.35  0.25 [48]
Wnt2 Wingless-related MMTV integration site 2 1.62 1.51 0.15 [27]
Wnt5a Wingless-related MMTV integration site 5a 1.58 1.48 0.36 0.07 0.05 [27]
DOI: 10.1371/journal.pgen.0020081.t001
PLoS Genetics | www.plosgenetics.org May 2006 | Volume 2 | Issue 5 | e81 0773
Epigenetics of Obesity in MiceWnt Signaling
An extensive series of investigations have implicated Wnt
signalingmolecules,especiallyWnt10b,asagentsthatmaintain
the preadipocyte compartment and inhibit their differentia-
tion into mature adipocytes [26,27]. Small changes were noted
in the expression of some members of the Wnt family, but not
Wnt 10b, nor in the levels of mRNA of their frizzled receptors;
however,thereproducibilityofchangesinthesegeneswerenot
conﬁrmed by qRT-PCR of RNA samples from individual mice
and multiple fat depots. On the other hand, increased levels of
expressionoftwoinhibitorsforWntsignaling,secretedfrizzled
related protein (SFRP) 5 and Naked1, were among the most
signiﬁcantly increased in expression in high gainers (Table 1).
The range in expression for SFRP5 was 30–44-fold depending
on the fat pad and that of Naked1 about 5 fold. SFRP5 and
Naked1 were predominantly expressed in the adipocyte
fraction (Figure 4). The expression of SFRP5, Naked1, MEST,
and Serpine1 were all elevated in three different fat depots of
high gainer mice (Figure 5). Regression analysis of SFRP5 to
adiposity indicates that variation in epididymal fat SFRP5 is
associated with as much as 45 % of the variance in adiposity (R
¼ 0.67; Figure 6). In addition, the high correlations between
SFRP5, Naked1, and MEST in inguinal fat depots suggest a
mechanism of coordinated regulation of the expression of
these genes in association with susceptibility to diet-induced
obesity (Figure 7).
Imprinted Genes
Four imprinted genes showed a highly signiﬁcant induction
in high gainers, particularly PEG1/MEST with a 23-fold
increase in the adipocytes of high gainers compared to low
gainers (Table 1). A detailed analysis of MEST expression is
being prepared for an independent publication.
Vascularization and Tissue Remodeling
Several genes with potential functions in the control of
vascularization show highly signiﬁcant differences in expres-
sion between high and low gainers. Of particular note
Serpine1 or plasminogen activator inhibitor 1, known to be
involved in vascularization and the control of adipogenesis,
was over-expressed in the inguinal and retroperitoneal fat
depots of high gainers (Figure 5). Angiotensinogen gene
expression was elevated in visceral fat, but not subcutaneous
fat as previously shown [28], but curiously the correlation
between angiotensinogen mRNA levels in retroperitoneal
and epididymal fat with adiposity among the 20 high gainers
and 20 low gainers was negative. Bone morphogenetic
protein 3 (BMP3), which is antagonistic to bone development
[29], showed a strong association with increased adiposity.
Molecular Correlates in the Pre-Obese State
Inspection of the chronological development of obesity
from weaning at 3 wk of age until 22 wk of age, during which a
high-fat diet was fed from 8 wk of age for 14 wk (including a
gap of 2 wk when mice received a restricted low-fat diet)
indicates that mice destined to become high gainers were
already beginning to show signs of increased adiposity at 6 wk
of age even before they were fed a high-fat diet (Figure 2). In
order to evaluate whether genes, which were found to be up-
regulated in obese mice, showed altered levels of expression
prior to being fed a high-fat diet, we performed an experi-
ment in which biopsies of epididymal fat were taken at 7 wk
of age and the mice were continued on the protocol of diet-
induced obesity by feeding the high-fat diet from 8–16 wk of
age. Gene expression in biopsied samples was determined
using the TaqMant Low Density Array described in Table 1 to
validate changes in the high density microarray analysis
(Figure 8). Only three genes, SFRP5, MEST, and BMP3,
Figure 4. Comparison of the Expression of Four Genes in the Mature
Adipocyte and Stromal Vascular Fraction of the Epididymal and Inguinal
Fat Pads Isolated from Four Pools of RNA Derived from Tissue Isolated
from Eight Mice
Each pool consisted of equal amounts of RNA from two mice. All
comparisons between adipocyte and stromal vascular fractions were
significant (p , 0.01) except for ING fat SFRP5 (p ¼ 0.09). EPI ¼
epididymal; ING ¼ Inguinal
DOI: 10.1371/journal.pgen.0020081.g004
Figure 5. Over-Expression of Four Genes in High Gainer Mice in Two
Peritoneal Fat Depots and One Subcutaneous Fat Depot Illustrates that
the Mechanism Leading to Over-Expression of These Genes Occurs in All
Fat Depots
Statistical significance was calculated by ANOVA. Twenty mice were
present in each group.
DOI: 10.1371/journal.pgen.0020081.g005
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present in the FM/LM index of the biopsied mice at 16 wk of
age (Figure 8A–8C). Thus, variation in expression of selected
genes implicated in diet-induced obesity was evident even
before the mice were submitted to an obesogenic environ-
ment. Furthermore, it was found that a signiﬁcant induction
of SFRP5 and MEST mRNA occurred after only 1 wk on a
high-fat diet (Figure 8D).
Discussion
Epigenetic Model of Obesity
The motive to explore the basis for highly variable obesity
phenotypes periodically observed to occur within inbred
strains of mice is that it intuitively suggests a model system to
identify regulatory mechanisms underlying obesity that are
independent of inherited mutations to the genome. If a
stable, though variable, obesity phenotype is present among
individual mice of a ‘‘normal’’ highly inbred strain, then it
may reﬂect the workings of an epigenetic mechanism for
obesity together with environmental and genetic mecha-
nisms. Given the strong opinions on the genetic versus
environmental basis for the obesity epidemic [30,31], a model
that establishes an epigenetic contribution to obesity would
be of signiﬁcant value. A major focus of this study has been to
establish rigorously the variable obesity phenotype in an
inbred strain, since it had previously been based upon
anecdotal observations of phenotypes of control mice in
studies of transgenic and knockout models of obesity. The
following evidence from our study is consistent with an
epigenetic mechanism underlying the variable obesity phe-
notypes present among male B6 mice fed a high-fat diet: 1) a
robust 4-fold range in the development of adiposity occurred
in a population of B6 male mice within 4 wk of being fed a
high-fat diet (Figure1); 2) the phenotypic differences were
stable, as shown in Figure 2, and remained so even after the
regimen of a high-fat diet fed ad libitum was interrupted by
feeding a restricted low-fat chow diet to reduce their
adiposity state; 3) variations in gene expression in 7-wk-old
mice prior to the introduction of an obesogenic diet
correlated with obesity phenotypes after 8 wk on a high-fat
diet (Figure 8).
Our model to explore the epigenetic basis of diet-induced
obesity is designed around a conscious effort to minimize
malnutrition and stress. The variation in litter size or wean
weight showed weak positive associations with diet-induced
obesity in the adult that contributed approximately 3% to the
variance in adiposity. In earlier stages of our study B6 dams
were fed a diet with 6.5% fat rather than the 11% fed during
later experiments and produced offspring with a wider range
of wean weights, but even with these animals the association
of wean weight with diet-induced obesity was always positive
(unpublished data). In contrast to these almost insigniﬁcant
associations between wean weights and adiposity, which were
estimated by regression analysis to contribute only ;3% to
the variance in adiposity after 4 wk on a high-fat diet, the
Figure 6. Positive Correlations between SFRP5 and Adiposity
Regression analysis between SFRP5 mRNA levels and adiposity as estimated by the ratio of FM to LM in ING, EPI, and RP fat from 112 Mice Described in
Figure 1B.
FM ¼ Fat Mass; LM ¼ Lean Mass; ING ¼ Inguinal; EPI ¼ Epididymal; RP ¼ Retroperitoneal
DOI: 10.1371/journal.pgen.0020081.g006
Figure 7. Coordinated Gene Expression
Regression analyses of SFRP5, MEST, and Naked mRNA levels in RNA isolated from high and low gainer mice in inguinal fat depots suggest that
regulation of this subset of genes share a common mechanism related to the degree of adiposity. Twenty mice were present in each group.
DOI: 10.1371/journal.pgen.0020081.g007
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high as 45% (Figure 6). A popular current model to
investigate nutritionally determined epigenetic programming
of obesity and type 2 diabetes has emerged from the fetal
origins hypothesis of Barker, in which individuals exposed to
malnutrition during in utero development have increased
susceptibility to obesity when exposed to an obesogenic
environment as an adult [32,33]. It is unclear whether the
mechanisms determining variations in obesity in the well
nourished animals of our studies have any relationship to
those by which nutritional programming in the malnourished
fetus predestines the individual by adaptation to become
obese, since in contrast to our model the low-birth-weight
individuals become more obese. However, it is not difﬁcult to
imagine how developmental genes, like SFRP5, BMP3, and
MEST, could also be involved in determining variations in
adipogenesis that are rooted in fetal malnutrition.
Physiological Mechanisms
The keystone of this obesity model is the difference in
adiposity that emerges following the feeding of a high-fat
diet. However, variation in adiposity may not be the primary
mechanism, rather changes in adiposity could also follow
from differences in the caloric load and these could be
determined by differences in food intake and/or in feeding
efﬁciency. The latter could be particularly complex and could
involve the processing of nutrients via the gastrointestinal
tract, energy metabolism in the periphery, and the efﬁciency
of fat storage. To obtain clues that implicate food intake or
feeding efﬁciency, we have related the development of the
adiposity among individual mice with changes in food intake
and calculated feeding efﬁciency. The results suggest that
differences in adiposity during the ﬁrst 3 wk of the high-fat
diet do not correlate with differences in either food intake or




th wk both feeding efﬁciency and food intake were
signiﬁcantly correlated with differences in adiposity (Figure
3). Since it is known that B6 mice with diet-induced obesity
develop resistance to peripheral leptin, as evidenced by the
effects on food intake [34] and the high gainers in our
experiment indeed have higher leptin levels than low gainers,
the changes in food intake and feeding efﬁciency that follow
the early differences in body weight could in part reﬂect the
effects of leptin resistance. Elevated levels of leptin expres-
sion would stimulate leptin resistance, which in turn would
lead to increased food intake and possible suppression of
energy expenditure as evidenced by the increased feeding
efﬁciency. Whatever the mechanism underlying differences in
food intake, no differences in gene expression could be
detected in the hypothalamus by microarray analysis and
qRT-PCR. The experiments have largely focused on the
phenotypes that emerge in the presence of an obesogenic
environment, i.e. a high-fat diet; however, our evidence
suggests that fundamental changes in the epigenetic status of
the genome of individual animals may be established prior to
the introduction of the high-fat diet. Recently studies
indicating that variations in the leptin surge during the
neonatal period can impact upon later susceptibility to
weight gain on a high-fat diet suggest that stochastically
determined variations in the leptin surge in B6 mice need to
be evaluated [35]. However, even if such a leptin-based
mechanism is involved in determining subsequent differences
in susceptibility to diet-induced obesity, understanding the
role of the developing adipose tissue as the source of the
leptin surge remains a key factor.
Assuming that variation in adiposity is determined
epigenetically; possibly by a mechanism involving chromatin
methylation, when during development does this occur? If
changes in the epigenetic state of the genome depend upon
an obesogenic environment, then the post-natal period when
adipose tissue is in its most active state of proliferation [36],
and when the fat content of the neo-natal diet approaches 55
Kcal% [37] would be an intriguing period within which to
search for establishing epigenetic modiﬁcation of chromatin
in adipocytes. Alternatively, epigenetic differences among
individuals may be stochastically determined at any stage of
development and the consequences of the variation become
evident under the appropriate conditions, the most impor-
tant of which appears to be the genetic background of the
animal and a high-fat diet to induce gene expression. The
presence of variations in the expression of SFRP5 and other
g e n e si n7 - w k - o l dm i c es u g g e s t st h a tm o d i ﬁ c a t i o n si n
chromatin structure that cause these variations among
individual mice exist prior to the introduction of an
obesogenic diet. However, it is unknown whether these
epigenetic variations are actually affecting the SFRP5 gene
or some upstream regulator.
Molecular Mechanisms
Our ﬁnding that highly signiﬁcant differences in expres-
sion occur for speciﬁc genes in metabolic pathways of
adipogenesis establishes that the molecular mechanisms for
the variation in obesity are not caused by random stochastic
variation in gene expression among individual animals, since
such random activations of gene expression would not lead to
Figure 8. Analysis of mRNA Levels in Biopsies of Epididymal Fat Depots
Taken from Mice 7 wk of Age prior to Feeding a High-Fat Diet Suggests
That Changes in Gene Expression Exist before Mice Are Exposed to an
Obesogenic Environment
Mean adiposity (FM/LM) at 16 wk of age for the mice with the highest
and lowest 20% expression of SFRP5 (A), MEST (B), and BMP3 (C) at 7 wk
of age. SFRP5 and MEST were assayed by qRT-PCR and BMP3 by a
TaqMant Low Density Array. Each bar represents the mean FM/LM 6
SEM for 12 mice. (D) Induction of SFRP5 and MEST mRNA levels after
being fed a high-fat diet at 8 wk of age for 1 wk.
DOI: 10.1371/journal.pgen.0020081.g008
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population. Rather, the microarray data and subsequent qRT-
PCR analyses of high and low gainers suggest that highly
signiﬁcant differences in gene expression within speciﬁc
molecular mechanisms of adipogenesis occur among a large
fraction of the mice. Molecular pathways of adipogenesis
have been extensively investigated during the past several
years [38,39]; however, it is not known whether unique
regulatory pathways exist that control the expansion of
adipose tissue mass during environmentally-induced obesity.
The analysis of data was based upon viewing the adipose
tissue as a composite of three compartments: 1) the mature
adipocyte, 2) the preadipocyte fraction, and 3) the vascular
epithelium. Partial information on genes that were prefer-
entially expressed in these compartments was obtained by
analyzing expression in mature adipocytes and cells from the
stromal vascular fraction. The complete gene expression
database was searched to evaluate the behavior of genes that
have previously been implicated in the three compartments
of adipogenesis. In addition, an important feature of the
analysis was to highlight not only genes with signiﬁcant
variation between high and low gainers, but to note the
absence of signiﬁcant changes in genes that are biomarkers of
the adipocyte or have been strongly implicated in adipo-
genesis. Accordingly, one of the major initial insights from
the gene expression data is the absence of changes between
high and low gainers in the expression of genes encoding
either the major transcription factors of adipogenesis or
biomarkers of the adipocyte, both of which are robustly
induced during in vivo adipogenesis and in cell culture
models [39]. A few transcription factors such as GATA3,
Lipin3, and Myc were variably expressed, but these may be
more involved in gene expression of cells in the stromal
vascular fraction, possibly preadipocytes.
Wnt Signaling
The characterization of Wnt10b expression with over-
expression and gene knockout models in cell culture and in
vivo has provided strong evidence that the Wnt signaling
pathway plays an important role in the differentiation of
adipocytes from mesenchymal precursors [27,40]. Wnt signal-
ing proceeds through the canonical pathway that stabilizes
cytoplasmic levels of b-catenin by dephosphorylation and
facilitates its translocation to the nucleus where it controls a
program of target gene expression in preadipocytes that
inhibits their progression to a mature adipocyte [41]. Gene
targets of the transcription mechanism act to suppress
PPARc expression and activate genes of osteogenesis [36].
Several regulators of the Wnt pathway have been identiﬁed;
some act by inhibiting the interaction of Wnt ligands with the
frizzled receptors, these include members of the SFRP family;
others like Dickkopf interfere with the formation of an active
frizzled receptor-LRP complex; and Naked1 is a protein that
interacts with Dishevelled to enhance the formation of the
axin-APC-GSK3 complex that promotes phosphorylation of
the b-catenin complex and its degradation by a proteasome-
mediated pathway [42].
Although forced expression of Wnt10b and SFRP1 in 3T3-
L1 cells and transgenic mice will inhibit or stimulate
preadipocyte differentiation, respectively, there is very little
evidence documenting the function of these components of
the pathway during adipogenesis in vivo [26,43]. In other
words, does Wnt10b play as central a role in the control of
adipogenesis in vivo as suggested from the published studies
or do other members of the pathway play additional
complementary roles? We have presented evidence on
signiﬁcant changes in the expression of additional genes
associated with Wnt signaling. Changes in expression were
small for Wnt2 and Wnt5a and for frizzled receptors, and not
detected for Wnt10b, the most thoroughly studied Wnt family
member. While differences in expression for these molecules
scarcely reached signiﬁcance, four genes (SFRP5, Dapper,
Dickkopf, and Naked1) with demonstrated functions as
inhibitors of Wnt signaling were highly up-regulated in high
gainers. A 30–40-fold variation in SFRP5 and 5-fold variation
in Naked1 mRNA levels were highly correlated with indices of
adiposity (R¼0.67; Figure 5 and 6), as well as with each other
and MEST with R values ranging between 0.8 and 0.93 (Figure
7). These associations between gene expression and variable
obesity phenotypes may merely indicate that the changes in
expression of SFRP5, MEST, and other genes only result as a
consequence of adiposity. To address this question we
assessed whether these genes have altered levels of expression
in the pre-obese state that correlate with susceptibility to
obesity that occurs following exposure to an obesogenic
environment. The results indicate that SFRP5, MEST, and
BMP3, but not Naked1, are positively associated with the
subsequent development of diet-induced obesity in 16 wk-old
mice. In addition, the induction of SFRP5 and MEST mRNA
levels after only 1 wk on a high-fat diet may indicate that
these genes are highly sensitive to the obesogenic environ-
ment. These genes may be regulated by transcription factors
that are responsive to ligands derived from the high-fat diet
or to morphological/mechanical changes induced by the
uptake of intracellular lipids when the high-fat diet is
introduced. The importance of cytoskeletal-derived forces
in the regulation of adipocyte differentiation was described
over 20 y ago by Spiegelman and Ginty [44] and more recently
McBeath et al [45] showed that a microenvironment that
changes the shape of stem cells in culture will determine
whether they differentiate into osteocytes or adipocytes.
Given the reciprocal response of mesenchymal stem cells to
proceed along either the osteogenesis or adipogenic pathways
[46], the increased expression of BMP3 which has been shown
to antagonize osteogenesis [29], is consistent with a role for
BMP3 in adipogenesis.
The function of Wnt signaling in adipogenesis, as eluci-
dated by the analysis of Wnt10b in 3T3-L1 cells, is based upon
maintaining the preadipocyte compartment, where Wnt10b
is exclusively expressed [27], through the control of cell
proliferation and apoptosis. The function of Wnt signaling in
diet-induced obesity is likely to be different, since SFRP5 is
predominantly expressed in the mature adipocyte and
Naked1 is expressed in both the mature adipocyte and
stromal-vascular fractions. The importance of SFRP5 as a
regulatory site in an epigenetic mechanism was recently
shown with the demonstration that methylation and repres-
sion of the promoters for SFRP1, 2, 4, and 5 in colorectal
tumor cells causes constitutive expression of Wnt signaling
and enhances tumor promotion. Accordingly, similar DNA -
methylation and/or histone modiﬁcations of the SFRP genes
in mice during diet-induced obesity are possible. While the
gene expression analyses of our study did not show signiﬁcant
differences in expression for the major transcription factors
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a role for transcription mechanisms of adipogenesis involving
protein phosphorylation or nuclear translocation that are
surely involved in regulating fat mass expansion in diet-
induced obesity.
Vascularization and Tissue Remodeling
It is clear from recent studies that differentiation and
expansion of adipose tissue mass are linked to mechanisms
associated with angiogenesis and vascularization. The fat mass
of the both genetic and diet-induced obesity of the mouse is
drastically reduced by inhibitors of angiogenesis [47], an
effect that is also observed in tissue culture models [48].
Plasminogen activator inhibitor 1 is elevated in both mouse
and human obesity [49], and mice carrying target mutations
to this gene have reduced obesity and improved insulin
resistance [50,51]. Other studies have shown important roles
for the Adamts disintegrin-protease system [52] and kallikrien
serine proteases associated with the plasminogen cascade for
the modeling of adipose tissue [53]. Therefore it is of
considerable interest that variation of these genes between
the high and low gainers are among the most robust
differences we have observed (Table 1) and suggests an
additional site for determining susceptibility to environ-
mentally induce obesity.
In summary, we have shown that individuals within an
inbred strain of mouse susceptible to diet-induced obesity
have a large variation in stable obesity phenotypes. We also
show that high gainers are more metabolically efﬁcient in the
conversion of caloric energy into body weight and eventually
have greater food intake; this is likely a secondary conse-
quence of early increases in fat mass and leptin production.
Gene expression analysis identiﬁed two important aspects of
adipocyte biology where variation in the adiposity could be
achieved. One is in reversing the inhibition of adipogenesis
from the mesenchymal cell compartment by Wnt signaling
mechanisms through the methylation-sensitive SFRPs and
BMP3, which have elevated expression in mice destined to
become high gainers even before they are fed a high-fat diet.
The other is in systems associated with vascularization and
tissue remodeling, the modulation of which strongly inﬂuen-
ces obesity [47,51]. This research underscores how variation
in energy balance in an inbred strain provides a model to
explore epigenetic mechanisms that are as powerful as
mutations to Mendelian genes in causing obesity. Parentheti-
cally, it becomes obvious that if there is a background of
stable variation in diet-induced obesity within in an inbred
strain that exceeds the quantitative contribution of any single
genetic locus, why it is so difﬁcult to identify obesity
quantitative trait loci. Finally, it is certain that the variable
molecular and physiological obesity phenotypes we have
described in this study represent the tip of the iceberg of a
plethora of variable, stable somatically heritable phenotypes
that are probably present within inbred strains and as shown
for the Axin gene, epigenetic inheritance can be inﬂuenced
by genetic background [54].
Materials and Methods
Animals. C57BL/6J breeders were obtained from the Jackson
Laboratory (Bar Harbor, Maine, United States). To minimize the
genetic drift from the colonies at the Jackson Laboratory breeding
stock was replaced every 2 y. All mice for the experiments were
generated on site at the Pennington Biomedical Research Center.
Animal rooms were maintained at 22–24 8C with a 12-h light/dark
cycle. Breeders were housed in plastic pens with corn-cob bedding
and fed a breeders diet 5015 ad libitum. From weaning until 8 wk of
age mice were fed a low-fat chow diet 5053 ad libitum. (Composition
of diets 5015 and 5053 are available from www.labdiet.com). At 8 wk
of age mice were fed ad libitum a high saturated fat diet D12331
(Research Diets, New Brunswick, New Jersey, United States) for
various periods of time as indicated by the experimental protocol.
The effects of a diet high in unsaturated fat was tested with a diet
formulated by Research Diets that was modeled after D12331 and
contained 16.5 kcal% protein, 38.5 kcal% carbohydrate, and 45.0
kcal% fat (4.8% hydrogenated coconut oil and 40.1% corn oil). From
weaning until 7 wk of age mice of the same sex were group housed (3–
5 mice per pen) until 7 wk of age, at which time they were singly
housed for the remainder of the experiment.
Epididymal fat biopsy. In 7-wk-old mice on a low-fat diet, the
caudoventral half of the abdomen was shaved to remove hair and
surgically prepped with three alternating scrubs of Nolvasan and
70% ethanol. An incision of the paramedian skin approximately 1.0–
1.5 cm was made in the right or left caudal quadrant, followed by a
0.5-cm incision through the abdominal wall to access the epididymal
fat depot. Thumb forceps were used to retract the epididymal fat
and approximately 100 mg of adipose tissue excised. The remaining
fat was replaced into the abdomen. The abdomen was closed in two
layers. First the abdominal wall was surtured using 4–0 Vicryl,
followed by wound clips to close the skin. Wound clips were
removed 7–10 d post operatively. All animal experiments were
approved by the Pennington Biomedical Research Center Institu-
tional Animal Care and Use Committee in accordance with NIH
guidelines.
Phenotyping. Adiposity was determined from body weights and
measurements of body composition by NMR (Bruker, The Wood-
lands, Texas, United States). Energy content of weight gain is based
upon an energy content of 30 kJ/g, if body composition is 60% fat
and 45 kJ/g if 100% [22]. Food intake was determined on a weekly
basis, unless otherwise indicated, by weighing the food remaining in
the food hopper. Energy content of the high-fat diet (D12331) is
23.29 kJ/g. Animals that spilled excessive food were not included in
the food intake data. At the conclusion of a particular experiment,
tissues were quickly removed and frozen in liquid nitrogen and
stored at  80 8C for subsequent preparation of total RNA. Total
RNA was isolated from adipose tissue and hypothalamus using TRI
Reagent (Molecular Research Center Inc. Cincinnati, Ohio, United
States) with modiﬁcations to remove DNA using the Qiagen
RNAeasy columns and DNaseI Kit (Qiagen, Valencia, California,
United States). RNA was stored at  70 8C in RNase-free H2O
supplemented with the RNase inhibitor Superasin (Ambion, Austin,
Texas, United States) per manufacturers directions. Quality and
quantity of RNA was determined using either UV spectrophotom-
etry and agarose gel visualization of intact RNA or by using the
Agilent Bioanalyzer as per manufacturers procedures (Agilent
Technologies, Palo Alto, California, United States). Quantitative
RT-PCR (qRT-PCR) using TaqMan probes and primers or Sybr green
(Applied Biosystems, Foster City, California, United States) was
performed essentially as described previously [55,56] except standard
curves were generated using pooled RNA from individual samples
within each experiment. Probe and primer sequences used to
perform the analyses are available upon request. Validation of the
expression levels of a large number genes identiﬁed by microarray
analysis (see below) was also performed by a custom-designed
TaqMant Low Density Array (Applied Biosystems, Foster City,
California, United States).
Microarray analysis. Gene expression proﬁles were generated
using Applied Biosystems Mouse Genome Survey Microarray. Each
microarray contains approximately 34,000 features that include a set
of about 1,000 controls. Each microarray uses 32,996 probes to
interrogate 32,381 curated genes representing 44,498 transcripts.
Prior to ampliﬁcation and labeling, the quality of total RNA
isolated from adipose tissue was determined using the Agilent 2100
Bioanalyzer. The RNA Integrity Number (RIN) of the RNA ranged
from 8.8–9.1. One lg of total RNA was used to transcribe DIG-labeled
cRNA using Applied Biosystems Chemiluminescent RT-IVT Kit v2.0.
Microarray hybridization (using 20 lg of fragented, DIG-labeled
cRNA and three microarrays per sample), processing, chemilumines-
cence detection, imaging, auto gridding, and image analysis was done
according to Applied Biosystems protocols and the 1700 Chemilu-
minescent Microarray Analyzer Software v. 1.0.3. Signal intensities
across microarrays were normalized using the quantile-quantile
method (http://www.bioconductor.org). Features with a signal/noise
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and were subjected to ANOVA analysis with p value of 0.01 using
Spotﬁre DecisionSite Software (Spotﬁre, Somerville, Massachusetts,
United States). The lists of differentially expressed genes with a cutoff
of 1.5 for over-expression in high and low gainers were then classiﬁed
using PANTHER ([57], http://www.panther.appliedbiosystems.com).
Supporting Information
Table S1. Microarray Analysis of the Hypothalamus of High and Low
Gainer Mice
Found at DOI: 10.1371/journal.pgen.0020081.st001 (131 KB PDF).
Accession Numbers
Microarray experiments, described according to MIAME guidelines,
have been deposited in NCBI’s Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo) repository with accession numbers
GSE4697 and GSE4692 for the hypothalamus and inguinal fat,
respectively.
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